Status:
ACTIVE_NOT_RECRUITING
Evaluating the Effects of Frozen Section Technology on Oncological and Functional Outcomes at Radical Prostatectomy.
Lead Sponsor:
University College, London
Collaborating Sponsors:
North Bristol NHS Trust
Sheffield Teaching Hospitals NHS Foundation Trust
Conditions:
Prostate Cancer
Eligibility:
MALE
18-75 years
Phase:
NA
Brief Summary
In summary this trial will test whether this new surgical technique can be used to make surgery safer and more effective whilst allowing improved quality of life for patients having surgery for prosta...
Detailed Description
Prostate cancer is very common and results in the death of many men in the developed world. Prostate cancer that has not spread outside the prostate can usually be cured by surgical removal of the pro...
Eligibility Criteria
Inclusion
- Men opting to undergo RARP for organ confined prostate cancer.
- Potent men (IIEF 22-25 not using PDE5i or other medications or vacuum pump)
- Men who are continent of urine (no self-reported urinary incontinence)
- Has given written informed consent
- Ability to read English sufficiently to answer questionnaires and understand PIS
Exclusion
- Unable to undergo robotic prostatectomy
- Known urinary incontinence
- Previous treatment for prostate cancer
- Previous/current hormone treatment for prostate cancer
- Nerve sparing deemed futile due to locally advanced disease by surgeon and radiologist
Key Trial Info
Start Date :
April 9 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2027
Estimated Enrollment :
407 Patients enrolled
Trial Details
Trial ID
NCT03317990
Start Date
April 9 2018
End Date
December 1 2027
Last Update
September 4 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
North Bristol NHS Trust
Bristol, United Kingdom, BS10 5NB
2
NHS Greater Glasgow & Clyde
Glasgow, United Kingdom
3
University College London Hospital
London, United Kingdom, NW1 2BU
4
Nottingham University Hospitals
Nottingham, United Kingdom